Contact us


Birinapant With 5-azacitidine in MDS Subjects Who Are Naïve, Have Relapsed or Are Refractory to 5-azacitidine Therapy

A Phase 1b/2a, Open-label, Non-randomized Study of Birinapant in Combination With 5-azacitidine in Subjects With Myelodysplastic Syndrome Who Are Naïve, Refractory or Have Relapsed to 5-azacitidine Therapy

For more information, please visit

Patient Population Investigational Product(s) Phase Status
Myelodysplastic Syndrome TL32711 (Birinapant) Ib/2a Closed to Accrual